The global Pharmaceutical R&D Outsourcing market is set to grow significantly, with a valuation of USD 84.01 billion in 2023 and expected to reach USD 150.04 billion by 2029, representing…
TNF Pharmaceuticals Launches Study Series to Preserve Lean Muscle Mass During GLP-1 Weight Loss Treatment TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical-stage biopharmaceutical company focused on developing innovative therapies for…
PFID Poll: Bipartisan Support for Continued Vaccine Availability and Concern Over Declining Childhood Vaccination Rates The Partnership to Fight Infectious Disease (PFID) has released the results of a public opinion…
ImmunityBio, Inc. (NASDAQ: IBRX) has announced a strategic collaboration and supply agreement with BeiGene, Ltd. (soon to be renamed BeOne Medicines, Ltd.), a global oncology company. The partnership will focus…
Leveragen Inc. and Moonlight Bio Forge Strategic Collaboration to Revolutionize T Cell Therapies for Cancer Treatment Leveragen Inc., a pioneering biotech company based in Boston, has announced a groundbreaking partnership…
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to developing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other severe conditions driven by protein growth factors, has…
Photonic Inc. Founder Dr. Stephanie Simmons to Speak at UNESCO’s International Year of Quantum Science and Technology Opening Ceremony Paris, France – February 4-5, 2025 – Photonic Inc., a global…
Arizona ADHD Center Expands with New Scottsdale Clinic, Enhancing ADHD Diagnosis and Treatment Arizona ADHD Center, a premier medical and behavioral health clinic specializing in ADHD diagnosis, treatment, and ongoing…
Global Nanoemulsions Market Report 2024-2030: Growth Trends, Applications, and Forecasts Nanoemulsions – Global Strategic Business Report,” providing an in-depth analysis of the expanding nanoemulsions market. This report examines industry trends,…
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025 in San Diego JCR Pharmaceuticals Co., Ltd. (TSE 4552), a leading global specialty pharmaceutical company, has announced its participation in…
Modella AI, a leader in generative and agentic artificial intelligence for biomedicine, has announced that its advanced generative AI co-pilot, PathChat DX, has been granted Breakthrough Device Designation by the…
GeminiBio Appoints Matt Stober to Board of Directors Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of raw materials to the biopharmaceutical and advanced therapy industries, has announced the appointment of…
